Physician profile
Fareed Riyaz
NPI 1023454279
$2,836.70
in general payments reported to CMS, 2019-2025
16 companies · $49.48 in 2025
The $49.48 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,032 · 2020: $111 · 2021: $89.22 · 2022: $512 · 2023: $43.08 · 2025: $49.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,463.36 | 2019-2025 | Ruby Coil |
| Medtronic USA, INC. | $757.92 | 2019 | |
| Seagen INC. | $119.84 | 2022 | |
| Inari Medical, INC. | $106.26 | 2022 | |
| Merck Sharp & Dohme LLC | $72.95 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.97 | 2022 | |
| Incyte Corporation | $48.52 | 2021-2022 | |
| Exelixis INC. | $34.99 | 2022 | |
| Amgen INC. | $26.03 | 2022 | |
| Eisai INC. | $24.60 | 2022 | |
| Siemens Medical Solutions USA, INC. | $23.37 | 2022 | |
| Mallinckrodt Hospital Products INC. | $22.12 | 2021 | |
| Boston Scientific Corporation | $21.69 | 2021 | |
| Terumo Medical Corporation | $20.82 | 2022 | |
| Angiodynamics, INC. | $20.42 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $13.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fareed Riyaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.